J&J Innovative Medicine
What is a gene mutation?
Experts aren’t sure why, but sometimes changes in DNA can trigger cancer to grow and spread. For DNA Day learn all about gene mutations—and Johnson & Johnson’s work developing new therapies to target these specific types of cancer.
What you need to know about Johnson & Johnson’s 2024 first-quarter earnings
Here’s an infographic breakdown of the company’s first-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.
What is an orphan drug?
The need for these rare disease therapies is strong, and access to them can be lifesaving. Here’s how Johnson & Johnson is innovating to help give patients options.
Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research
Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
Johnson & Johnson named a 2024 Fortune World’s Most Admired Company
The company makes the list for the 22nd year in a row, thanks to its dedication to innovation, social responsibility and more.
Is this the end of one-size-fits-all treatments for depression?
For Mental Health Month, learn how Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
3 ways Johnson & Johnson is helping make healthcare more sustainable
Climate change is intertwined with just about every industry worldwide, including healthcare. For Earth Day, here’s a look at how Johnson & Johnson is taking action to help support a healthy planet.
Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way
The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
What it’s like when your baby has a rare blood disorder
A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.